Letter: Treatment of Huntington's chorea.
D000547:Amantadine / Q000627:therapeutic use*; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001545:Benserazide / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003975:Diazepam / Q000008:administration & dosage* / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006220:Haloperidol / Q000008:administration & dosage; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy*; D006834:Hydrazines / Q000008:administration & dosage*; D012110:Reserpine / Q000008:administration & dosage* / Q000627:therapeutic use
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D006834:Hydrazines; D004295:Dihydroxyphenylalanine; D001545:Benserazide; D012110:Reserpine; D000547:Amantadine; D006220:Haloperidol; D003975:Diazepam